 | • レポートコード：MRC2012A6638 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、経口コレラワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。経口コレラワクチンの種類別市場規模（シャンコル、ドゥコラル、ヴァクスコラ、その他）、用途別市場規模（病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：PaxVax、EuBiologics、Sanofi、Valneva、 ・地域別グローバル市場分析 2015年-2020年 ・経口コレラワクチンの北米市場（アメリカ、カナダ、メキシコ） ・経口コレラワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・経口コレラワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・経口コレラワクチンの南米市場（ブラジル、アルゼンチン） ・経口コレラワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：シャンコル、ドゥコラル、ヴァクスコラ、その他 ・用途別分析：病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Oral Cholera Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oral Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oral Cholera Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oral Cholera Vaccine market has been segmented into
Shanchol
Dukoral
Vaxchora
Others
By Application, Oral Cholera Vaccine has been segmented into:
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Cholera Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Cholera Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Cholera Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Oral Cholera Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oral Cholera Vaccine Market Share Analysis
Oral Cholera Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Cholera Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Cholera Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Oral Cholera Vaccine are:
PaxVax
EuBiologics
Sanofi
Valneva
Among other players domestic and global, Oral Cholera Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Cholera Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Cholera Vaccine, with price, sales, revenue and global market share of Oral Cholera Vaccine in 2018 and 2019.
Chapter 3, the Oral Cholera Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Cholera Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oral Cholera Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oral Cholera Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Oral Cholera Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Cholera Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Cholera Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Overview of Global Oral Cholera Vaccine Market
1.4.1 Global Oral Cholera Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 PaxVax SWOT Analysis
2.1.4 PaxVax Product and Services
2.1.5 PaxVax Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 EuBiologics
2.2.1 EuBiologics Details
2.2.2 EuBiologics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 EuBiologics SWOT Analysis
2.2.4 EuBiologics Product and Services
2.2.5 EuBiologics Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Valneva
2.4.1 Valneva Details
2.4.2 Valneva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Valneva SWOT Analysis
2.4.4 Valneva Product and Services
2.4.5 Valneva Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oral Cholera Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oral Cholera Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Cholera Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Oral Cholera Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oral Cholera Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Cholera Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oral Cholera Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oral Cholera Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Oral Cholera Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Oral Cholera Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oral Cholera Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Cholera Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oral Cholera Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
6.4 France Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oral Cholera Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oral Cholera Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oral Cholera Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
7.5 India Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oral Cholera Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Oral Cholera Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Oral Cholera Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oral Cholera Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oral Cholera Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oral Cholera Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oral Cholera Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Oral Cholera Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Oral Cholera Vaccine Price by Type (2015-2020)
11 Global Oral Cholera Vaccine Market Segment by Application
11.1 Global Oral Cholera Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Oral Cholera Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Oral Cholera Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oral Cholera Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Oral Cholera Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Oral Cholera Vaccine Market Forecast (2021-2025)
12.2.2 Europe Oral Cholera Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oral Cholera Vaccine Market Forecast (2021-2025)
12.2.4 South America Oral Cholera Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oral Cholera Vaccine Market Forecast (2021-2025)
12.3 Oral Cholera Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Oral Cholera Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Oral Cholera Vaccine Market Share Forecast by Type (2021-2025)
12.4 Oral Cholera Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Oral Cholera Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Oral Cholera Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oral Cholera Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oral Cholera Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oral Cholera Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. PaxVax Basic Information, Manufacturing Base and Competitors
Table 8. PaxVax Oral Cholera Vaccine Major Business
Table 9. PaxVax Oral Cholera Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. PaxVax SWOT Analysis
Table 11. PaxVax Oral Cholera Vaccine Product and Services
Table 12. PaxVax Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 14. EuBiologics Oral Cholera Vaccine Major Business
Table 15. EuBiologics Oral Cholera Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. EuBiologics SWOT Analysis
Table 17. EuBiologics Oral Cholera Vaccine Product and Services
Table 18. EuBiologics Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Oral Cholera Vaccine Major Business
Table 21. Sanofi Oral Cholera Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Sanofi SWOT Analysis
Table 23. Sanofi Oral Cholera Vaccine Product and Services
Table 24. Sanofi Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Valneva Basic Information, Manufacturing Base and Competitors
Table 26. Valneva Oral Cholera Vaccine Major Business
Table 27. Valneva Oral Cholera Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Valneva SWOT Analysis
Table 29. Valneva Oral Cholera Vaccine Product and Services
Table 30. Valneva Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Oral Cholera Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 32. Global Oral Cholera Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Oral Cholera Vaccine Sales by Regions (2015-2020) (K Units)
Table 34. Global Oral Cholera Vaccine Sales Market Share by Regions (2015-2020)
Table 35. Global Oral Cholera Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Oral Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 37. North America Oral Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 38. North America Oral Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Oral Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Table 40. Europe Oral Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 41. Europe Oral Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 42. Europe Oral Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Oral Cholera Vaccine Sales by Regions (2015-2020) (K Units)
Table 44. Asia-Pacific Oral Cholera Vaccine Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Oral Cholera Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Oral Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 47. South America Oral Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 48. South America Oral Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Oral Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Oral Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 51. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Oral Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Oral Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Table 54. Global Oral Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 55. Global Oral Cholera Vaccine Sales Share by Type (2015-2020)
Table 56. Global Oral Cholera Vaccine Revenue by Type (2015-2020) (USD Million)
Table 57. Global Oral Cholera Vaccine Revenue Share by Type (2015-2020)
Table 58. Global Oral Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 59. Global Oral Cholera Vaccine Sales Share by Application (2015-2020)
Table 60. Global Oral Cholera Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 61. Global Oral Cholera Vaccine Market Share Forecast by Regions (2021-2025)
Table 62. Global Oral Cholera Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 63. Global Oral Cholera Vaccine Market Share Forecast by Type (2021-2025)
Table 64. Global Oral Cholera Vaccine Sales Forecast by Application (2021-2025)
Table 65. Global Oral Cholera Vaccine Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oral Cholera Vaccine Picture
Figure 2. Global Sales Market Share of Oral Cholera Vaccine by Type in 2019
Figure 3. Shanchol Picture
Figure 4. Dukoral Picture
Figure 5. Vaxchora Picture
Figure 6. Others Picture
Figure 7. Oral Cholera Vaccine Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Research & Academic Laboratories Picture
Figure 10. Pharmaceutical & Biotechnology Companies Picture
Figure 11. Others Picture
Figure 12. Global Oral Cholera Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Oral Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Oral Cholera Vaccine Sales Market Share by Manufacturer in 2019
Figure 33. Global Oral Cholera Vaccine Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Oral Cholera Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Oral Cholera Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Oral Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Oral Cholera Vaccine Revenue Market Share by Regions (2015-2020)
Figure 40. Global Oral Cholera Vaccine Revenue Market Share by Regions in 2018
Figure 41. North America Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Europe Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 44. South America Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Oral Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 46. North America Oral Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Oral Cholera Vaccine Sales Market Share by Countries (2015-2020)
Figure 48. North America Oral Cholera Vaccine Sales Market Share by Countries in 2018
Figure 49. North America Oral Cholera Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Oral Cholera Vaccine Revenue Market Share by Countries in 2018
Figure 51. United States Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Oral Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Oral Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Oral Cholera Vaccine Revenue Market Share by Countries in 2019
Figure 57. Germany Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Oral Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Oral Cholera Vaccine Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Oral Cholera Vaccine Revenue Market Share by Regions 2019
Figure 65. China Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Oral Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Oral Cholera Vaccine Sales Market Share by Countries in 2019
Figure 72. South America Oral Cholera Vaccine Revenue Market Share by Countries in 2019
Figure 73. Brazil Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Oral Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Oral Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Oral Cholera Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Oral Cholera Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Oral Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Oral Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Oral Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Oral Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Oral Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
コレラワクチン経口ライブの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cholera Vaccines Oral Live market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cholera Vaccines O…- 経口生コレラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Live Cholera Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Live Cholera …
- 全細胞コレラワクチンの世界市場（～2026年） Whole Cell Cholera Vaccine is used to prevent Cholera. The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries. Market Ana…
- 経口ワクチンの世界市場（～2026年） Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery …
- 腸チフスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Typhoid Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Typhoid Vaccine market report…